Albert Hasson

1.4k total citations
27 papers, 881 citations indexed

About

Albert Hasson is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Albert Hasson has authored 27 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 13 papers in Public Health, Environmental and Occupational Health and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Albert Hasson's work include Substance Abuse Treatment and Outcomes (18 papers), Opioid Use Disorder Treatment (13 papers) and HIV, Drug Use, Sexual Risk (6 papers). Albert Hasson is often cited by papers focused on Substance Abuse Treatment and Outcomes (18 papers), Opioid Use Disorder Treatment (13 papers) and HIV, Drug Use, Sexual Risk (6 papers). Albert Hasson collaborates with scholars based in United States, Iraq and Canada. Albert Hasson's co-authors include Walter Ling, Richard A. Rawson, Christie Thomas, Maureen Hillhouse, Steven Shoptaw, Petra Jacobs, Michael McCann, Jeanne L. Obert, Patricia Marinelli‐Casey and Paul Brethen and has published in prestigious journals such as PLoS ONE, Addiction and Drug and Alcohol Dependence.

In The Last Decade

Albert Hasson

26 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Hasson United States 16 524 450 158 129 121 27 881
Soraya Mayet United Kingdom 15 564 1.1× 657 1.5× 101 0.6× 217 1.7× 119 1.0× 25 984
Jennifer Jackson Bloom United States 15 540 1.0× 513 1.1× 123 0.8× 198 1.5× 171 1.4× 19 968
Carmen L. Masson United States 20 727 1.4× 462 1.0× 101 0.6× 156 1.2× 237 2.0× 54 1.3k
R. Jeffrey Goldsmith United States 16 571 1.1× 438 1.0× 170 1.1× 122 0.9× 113 0.9× 32 1.1k
Jeffrey J. Annon United States 10 377 0.7× 360 0.8× 98 0.6× 95 0.7× 131 1.1× 17 626
Donald J. Tusel United States 12 664 1.3× 780 1.7× 212 1.3× 192 1.5× 84 0.7× 14 1.1k
Emma Black Australia 13 436 0.8× 243 0.5× 114 0.7× 124 1.0× 133 1.1× 28 741
Sharon Stancliff United States 15 551 1.1× 584 1.3× 66 0.4× 153 1.2× 100 0.8× 18 845
Leif Grönbladh Sweden 10 411 0.8× 456 1.0× 101 0.6× 141 1.1× 53 0.4× 17 704
Ambros Uchtenhagen Switzerland 18 1.0k 2.0× 960 2.1× 186 1.2× 202 1.6× 171 1.4× 87 1.6k

Countries citing papers authored by Albert Hasson

Since Specialization
Citations

This map shows the geographic impact of Albert Hasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Hasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Hasson more than expected).

Fields of papers citing papers by Albert Hasson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Hasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Hasson. The network helps show where Albert Hasson may publish in the future.

Co-authorship network of co-authors of Albert Hasson

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Hasson. A scholar is included among the top collaborators of Albert Hasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Hasson. Albert Hasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasson, Albert, et al.. (2023). Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana. Journal of Substance Use and Addiction Treatment. 151. 209032–209032. 4 indexed citations
2.
Mao, Yurong, Zunyou Wu, Jennifer M. McGoogan, et al.. (2017). Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol. BMC Health Services Research. 17(1). 397–397. 3 indexed citations
3.
Dabbagh, Rufaidah, Neeraj Kak, Jane Carlisle Maxwell, et al.. (2017). Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014. Addiction. 112(8). 1470–1479. 34 indexed citations
4.
Mao, Yurong, Zhenzhu Tang, Julio Montaner, et al.. (2016). Loss to Follow-Up from HIV Screening to ART Initiation in Rural China. PLoS ONE. 11(10). e0164346–e0164346. 9 indexed citations
5.
Mooney, Larissa J., Maureen Hillhouse, Christopher P. Thomas, et al.. (2015). Psychiatric symptoms and treatment outcomes in cocaine-dependent adults treated with buprenorphine and long-acting naltrexone. Drug and Alcohol Dependence. 156. e157–e158. 1 indexed citations
6.
Lindblad, R., Jennifer McCormack, Andrew J. Saxon, et al.. (2014). Induction onto extended-release naltrexone in 302 cocaine-dependent opioid users. Drug and Alcohol Dependence. 140. e124–e124.
7.
8.
Nielsen, Suzanne, Maureen Hillhouse, Christie Thomas, Albert Hasson, & Walter Ling. (2012). A Comparison of Buprenorphine Taper Outcomes Between Prescription Opioid and Heroin Users. Journal of Addiction Medicine. 7(1). 33–38. 38 indexed citations
9.
Mooney, Larissa J., Suzanne Nielsen, Andrew J. Saxon, et al.. (2012). Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology. Contemporary Clinical Trials. 34(2). 196–204. 15 indexed citations
10.
Saxon, Andrew J., Walter Ling, Maureen Hillhouse, et al.. (2012). Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial. Drug and Alcohol Dependence. 128(1-2). 71–76. 83 indexed citations
11.
Ling, Walter, Petra Jacobs, Maureen Hillhouse, et al.. (2010). From research to the real world: Buprenorphine in the decade of the Clinical Trials Network. Journal of Substance Abuse Treatment. 38. S53–S60. 37 indexed citations
12.
Weiss, Roger D., Jennifer Sharpe Potter, Scott E. Provost, et al.. (2010). A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodology. Contemporary Clinical Trials. 31(2). 189–199. 69 indexed citations
13.
Ling, Walter, Maureen Hillhouse, Catherine P. Domier, et al.. (2009). Buprenorphine tapering schedule and illicit opioid use. Addiction. 104(2). 256–265. 95 indexed citations
14.
Nyamathi, Adeline, Peggy Compton, Allan Cohen, et al.. (2009). Correlates of Hospitalization for Alcohol-Using Methadone-Maintained Persons With Physical Health Problems. Western Journal of Nursing Research. 31(4). 525–543. 5 indexed citations
15.
Hubbard, Robert L., Jeffrey D. Leimberger, Louise Haynes, et al.. (2007). Telephone Enhancement of Long‐term Engagement (TELE) in Continuing Care for Substance Abuse Treatment: A NIDA Clinical Trials Network (CTN) study. American Journal on Addictions. 16(6). 495–502. 42 indexed citations
16.
Rawson, Richard A., Albert Hasson, Alexander Huber, Monica J. McCann, & Walter Ling. (1998). A 3‐year progress report on the implementation of LAAM in the United States. Addiction. 93(4). 533–540. 28 indexed citations
17.
Grella, Christine E., et al.. (1996). What happens when a demonstration project ends. Journal of Substance Abuse Treatment. 13(3). 249–256. 13 indexed citations
18.
Rawson, Richard A., Steven Shoptaw, Jeanne L. Obert, et al.. (1995). An intensive outpatient approach for cocaine abuse treatment. Journal of Substance Abuse Treatment. 12(2). 117–127. 155 indexed citations
19.
Grella, Christine E., M. Douglas Anglin, Stuart E. Wugalter, Richard A. Rawson, & Albert Hasson. (1994). Reasons for Discharge from Methadone Maintenance for Addicts at High Risk of HIV Infection or Transmission. Journal of Psychoactive Drugs. 26(2). 223–232. 24 indexed citations
20.
Suárez, Carlos, et al.. (1986). High-dose steroids in childhood acute idiopathic thrombocytopenia purpura.. PubMed. 8(2). 111–5. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soraya Mayet Breakdown of academic impact, for papers by Jennifer Jackson Bloom Breakdown of academic impact, for papers by Carmen L. Masson Breakdown of academic impact, for papers by R. Jeffrey Goldsmith Breakdown of academic impact, for papers by Jeffrey J. Annon Breakdown of academic impact, for papers by Donald J. Tusel Breakdown of academic impact, for papers by Emma Black Breakdown of academic impact, for papers by Sharon Stancliff Breakdown of academic impact, for papers by Leif Grönbladh Breakdown of academic impact, for papers by Ambros Uchtenhagen
Rankless by CCL
2026